Acumen Pharmaceuticals, Inc. (ABOS): Price and Financial Metrics
ABOS Price/Volume Stats
| Current price | $1.06 | 52-week high | $3.92 |
| Prev. close | $1.13 | 52-week low | $0.86 |
| Day low | $1.05 | Volume | 82,188 |
| Day high | $1.15 | Avg. volume | 256,640 |
| 50-day MA | $1.16 | Dividend yield | N/A |
| 200-day MA | $2.06 | Market Cap | 64.21M |
ABOS Stock Price Chart Interactive Chart >
Acumen Pharmaceuticals, Inc. (ABOS) Company Bio
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, which is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is based in Charlottesville, Virginia.
ABOS Price Returns
| 1-mo | -1.40% |
| 3-mo | -29.33% |
| 6-mo | -62.74% |
| 1-year | -67.38% |
| 3-year | -73.70% |
| 5-year | N/A |
| YTD | -38.37% |
| 2024 | -55.21% |
| 2023 | -28.89% |
| 2022 | -20.12% |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...